AJOY CHAKRABARTI | Portfolio And Platform Lead
The Bill & Melinda Gates Foundation

Ajoy Chakrabarti has over 25 years of diverse product development experience in both pharmaceutical and biotechnology companies. He joined the Gates Foundation in 2016 as the Platform & Portfolio Lead for Polio. The role involves working across multiple polio vaccine programs to provide strategic guidance and product development expertise as part of the global effort to eradicate polio. He spent the prior eight years leading cross-functional development teams working on anthrax therapeutics and vaccines, as well as nerve agent antidotes prior to joining the Foundation. His experience on the commercial side of pharma while at Bristol-Myers Squibb including working in marketing, portfolio management, decision analysis and forecasting.  His expertise includes the following areas: preparing for Disease X; biodefense products; infectious diseases; oncology; and metabolic diseases. He did his undergraduate studies at Carleton University (BSc. Biochemistry & MSc.), received his PhD (Biochemistry) from the University of British Columbia and his MBA from Cornell.